Adma Biologics (ADMA) shares soared 10.2% in the last trading session to close at $20.61. The move was backed by solid volume with far more shares changing hands than in a normal session.

Reports Q4 revenue $117.55M, consensus $112.8M. “ADMA delivered exceptional operating and financial results in 2024, with total revenues and Adjusted EBITDA growing 65% and 309% year-over-year ...

In the latest trading session, Adma Biologics (ADMA) closed at $18.67, marking a +1.3% move from the previous day. The stock outpaced the S&P 500's daily gain of 0.64%. Elsewhere, the Dow saw an ...

Pre-earnings options volume in Adma Biologics (ADMA) is 2.8x normal with calls leading puts 12:1. Implied volatility suggests the market is anticipating a move near 11.5%, or $1.87, after results ...

You have a love and a talent for singing, acting, dancing, or playing music. At RIT, we not only hope you’ll continue participating in the performing arts, we absolutely encourage it through the ...

ADMA Biologics (NASDAQ:ADMA) traded lower on Tuesday after the plasma-based treatment developer announced a delay in its 10-K filing, even as its Q4 2024 results released in the aftermarket ...

Adma Biologics (ADMA) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.

The School of Performing Arts is home to courses, minors and immersions and performances in the areas of music, theatre, and dance. The school offers the opportunity both in and out of the classroom ...

The Master’s in Arts Management and Entrepreneurship enables you to deepen your abilities as a performer while gaining knowledge and skills that prepare you for a diverse range of career options in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...